Pharmaceutical industry drugs

Wilson S, Bergsma DJ Orphan G-pro-tein-coupled receptors novel drug targets for the pharmaceutical industry. Drug Des Discov 2000 17 105-114. 

Including, but not restricted to, patients and their representatives, consumers, health professionals, researchers, academia, media, pharmaceutical industry, drug regulators, governments and international organisations. 

In many instances in the pharmaceutical industry, drug products may be manufactured in a variety of strengths (e.g., levothyroxine tablets in strengths of 50, 100, 150, 200, 500, and 750 xg). To develop and validate these potency methods, three strategies may be followed. 

Association for Clinical Research in the Pharmaceutical Industry Drug Information Association... 

Browne LJ, L.Taylor L. Predictive chemoinformatics Applications to the pharmaceutical industry. Drug Discov World 2002 2-8. 

Information about pharmaceutical industry drugs and research from the Internet service PharmInfoNet. 

Kinter, L. B., K. A. Gossett, and W. D. Kerns. 1994. Status of safety pharmacology in the pharmaceutical industry. Drug Development Research 32 208-216. 

Drews J, Ryser S (1996). Innovation deficit in the pharmaceutical industry. Drug Inform. J. 30 97-107. 

Senn SJ (1998a) Further statistical issues in project prioritization in the pharmaceutical industry. Drug Information Journal 32 253-259. 

Ivanisevic I, Bates S, Chen P (2009) Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions. J Pharm Sci 98 3373-3386 Ivanisevic I, McClurg RB, Schields PJ, Gad SC (2010) Uses of X-ray powder diffraction in the pharmaceutical industry drug discovery, development, and manufacturing, pharmaceutical sciences... 

---